BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $11,886,000 | +11.4% | 9,017,000 | +0.1% | 0.00% | -20.0% |
Q2 2018 | $10,671,000 | +29.2% | 9,008,000 | +20.1% | 0.01% | +25.0% |
Q1 2018 | $8,259,000 | +10.7% | 7,500,000 | +19.0% | 0.00% | +33.3% |
Q4 2017 | $7,462,000 | -1.0% | 6,300,000 | 0.0% | 0.00% | -25.0% |
Q3 2017 | $7,540,000 | +0.6% | 6,300,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $7,493,000 | -15.4% | 6,300,000 | -16.0% | 0.00% | -20.0% |
Q1 2017 | $8,855,000 | +0.8% | 7,500,000 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $8,789,000 | -2.1% | 7,500,000 | +4.2% | 0.01% | 0.0% |
Q3 2016 | $8,978,000 | -8.6% | 7,200,000 | -15.3% | 0.01% | -16.7% |
Q2 2016 | $9,828,000 | -12.7% | 8,500,000 | -10.5% | 0.01% | -14.3% |
Q1 2016 | $11,263,000 | -14.1% | 9,500,000 | -3.2% | 0.01% | -12.5% |
Q4 2015 | $13,109,000 | +3.5% | 9,810,000 | +4.0% | 0.01% | 0.0% |
Q3 2015 | $12,671,000 | -15.6% | 9,430,000 | 0.0% | 0.01% | -11.1% |
Q2 2015 | $15,018,000 | -14.5% | 9,430,000 | -18.7% | 0.01% | -10.0% |
Q1 2015 | $17,567,000 | +23.6% | 11,600,000 | 0.0% | 0.01% | +25.0% |
Q4 2014 | $14,217,000 | +59.5% | 11,600,000 | +42.5% | 0.01% | +60.0% |
Q3 2014 | $8,913,000 | +55.6% | 8,140,000 | +49.6% | 0.01% | +66.7% |
Q2 2014 | $5,729,000 | +16.5% | 5,440,000 | +25.6% | 0.00% | 0.0% |
Q1 2014 | $4,917,000 | +22.6% | 4,331,000 | +15.5% | 0.00% | +50.0% |
Q4 2013 | $4,010,000 | – | 3,750,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |